Charles & Colvard, Ltd.
After Hours:
Closed: Dec 3, 4:39:42 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
Day range
$2.83 - $2.95
Year range
$1.18 - $3.66
Market cap
87.29M USD
P/E ratio
Dividend yield
Primary exchange
Market news
Financial performance
(USD)Sep 2021Year/year change
Net income
Diluted EPS0.030.00%
Net profit margin8.04%-27.11%
Operating income1.18M23.79%
Net change in cash-2.28M-201.82%
Cash on hand14.12M2.62%
Cost of revenue4.78M16.24%
Charles & Colvard, Ltd., is a Research Triangle Park, North Carolina-based publicly traded company that distributes and manufactures jewelry. It was founded in 1995 by Charles Eric Hunter under the name C3 Inc., and then run by his brother Jeff Hunter until 2000. The company changed its name to Charles & Colvard in 1999. The company employs 63 people full-time, and generated $32.4 million in revenue during the year ending June 30, 2019, up from $27.91 million in the previous year. Charles & Covard was the first company to produce and sell synthetic moissanite, under U.S. patent US5723391 A, first filed by C3 Inc., North Carolina. The gemstones are made from silicon carbide crystals, supplied under an exclusive agreement from fellow North Carolina company Cree Inc. since 2014. In June 2019 the company netted $10 million from a secondary public offering. In March 2020, the company was notified that they were at risk of being delisted on NASDAQ, as their share price had been consistently below $1. Don O'Connell was announced CEO in May 2020, taking over after Suzanne T. Miglucci's resignation. Wikipedia
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more